Solutions›Patient ServicesUpdated

The Patient Support Program (PSP) Platform for Pharma.

From enrolment to therapy maintenance — a single platform with AI agents across the entire patient journey. Deployed in weeks, customised per therapy and market.

Talk to our PSP team
Therapies poweredOpdivoKeytrudaDupixentDarzalex Faspro

Patient Support Programs for Oncology, Rare Disease, and Specialty Pharma

Zelthy PSP templates are pre-built for the workflows, patient populations, and regulatory requirements of major therapy areas — deployed across India, the US, EU, and APAC. HIPAA, GDPR, and GxP compliant.

OncologyRare DiseaseImmunologyNeurologyCardiology
Our perspective

$5B in PSP spending. 3% patient enrolment.

PATIENT JOURNEY · END TO END1STARTEnrollmentAI VERIFICATION2VERIFYBenefitsAUTO VERIFY3MONITORAdherencePREDICT DROP-OFFRisk scoring · Interventions4ENGAGECall CentreLIVE AE DETECT5REPORTOutcomesReal-time PRO dataAI AGENTS ACTIVE ACROSS ALL STAGES

The industry spends billions on patient support programs that most patients never touch. Fragmented vendors, disconnected systems, and reactive workflows mean coordinators spend more time on data entry than patient interaction.

Zelthy approaches patient services differently. Every template ships with AI agents that automate the repetitive — enrolment validation, call scheduling, adherence prediction — so your team focuses on work that actually moves patient outcomes.

How Zelthy Compares

Zelthy vs traditional patient support program vendors

Traditional VendorsManual / SpreadsheetZelthy
Deploy time6–18 monthsNo timeline4–8 weeks
EnrolmentPaper / faxManualDigital, automated
AI agentsNoneNoneBuilt-in
AdherenceReactiveManualPredictive
ComplianceVariesUncontrolledHIPAA · GDPR · GxP
Code ownershipVendor lock-inN/AFully owned
The patient journey

End-to-end patient support program operations — from identification to outcomes.

This is the operational landscape Zelthy covers — the full patient lifecycle, not just isolated workflows.

Finding the right patients, at the right time

The journey starts when a patient is diagnosed and becomes eligible for a support program. HCPs need referral pathways, eligibility rules vary by therapy, and most programs miss 90%+ of eligible patients because identification relies on manual processes.

Without a platform

HCPs don't know the program exists. Eligibility rules are buried in PDFs. Patients fall through the gap between diagnosis and enrolment.

With Zelthy

Digital referral portals for HCPs. Automated eligibility screening against therapy-specific rules. AI agents that surface patients likely to benefit based on clinical and claims signals.

From scoping to live patients

PSP deployed in 4–8 weeks. Platform owned over time.

Every patient services engagement follows the same arc: deep operational mapping, rapid deployment on pre-built templates, continuous optimisation, and progressive ownership transfer to your team.

Your therapy. Your market. Your constraints.

Every PSP starts with the specific therapy, patient population, and regulatory environment. Zelthy's team works alongside your patient services and medical affairs teams to map the operational workflow — enrolment rules, communication cadences, adherence triggers, compliance requirements — before a single screen is designed. This isn't a generic discovery. It's informed by 20+ similar programs across oncology, immunology, and rare disease.

Outcome

Complete operational blueprint tailored to your therapy and market

Timeline
1–2 weeks
45%
adherence improvement
60%
faster enrolment
65%
reduction in approval time
30%
lower operational costs
Proof

Patient support programs live at top-10 pharma — across therapies and markets.

Oncology · PSPAustralia · Multi-site
Read the full story →

A global top-10 pharma company needed to replace a manual, paper-based PSP for a flagship oncology therapy that was reaching fewer than 5% of eligible patients.

45% adherence improvement60% faster enrolment30% cost reduction6-week deployment
Specialty · Compassionate AccessAustralia · National
Read the full story →

A leading pharma company's compassionate access program was losing patients in a 12-step manual approval process that averaged 22 days from request to medication dispatch.

65% faster approvals40% lower operational costsReal-time tracking5-week deployment
Use Cases

Everything we can deploy for Patient Services.

Digital PSP Platform

End-to-end patient support — enrollment, adherence monitoring, call scheduling, outcomes tracking.

Direct to Patient

Home delivery coordination, nursing visits, injection training, and self-administration support.

Patient Enrollment & Onboarding

Digital self-service enrollment with document verification, eligibility checks, and consent management.

Benefits Verification & Co-pay

Automated insurance benefits investigation, prior authorization tracking, co-pay cards, and financial assistance.

Call Centre Operations

AI-augmented call centre with real-time compliance monitoring, post-call documentation, and AE detection.

Patient Education & Engagement

Personalized content delivery across SMS, email, app, and WhatsApp — timed to treatment milestones.

Digital Health Campaigns

Disease awareness and therapy initiation — landing pages, HCP finder, consultation booking, funnel tracking.

Nurse Navigator Platform

Coordination for nurse educators — patient assignment, visit scheduling, documentation, outcomes reporting.

Medication Adherence Monitoring

Continuous adherence tracking via refill data, wearables, PROs, and pharmacy claims — proactive interventions.
Explore use cases across all verticals
FAQ

Frequently asked questions

A patient support program platform is software that helps pharmaceutical companies manage the end-to-end patient journey — from enrolment and benefits verification through adherence monitoring and outcomes reporting. It replaces fragmented manual workflows with a unified digital system, enabling coordinators to focus on patient interactions rather than data entry. Modern PSP platforms include AI-driven automation for tasks like eligibility screening, call scheduling, and treatment drop-off prediction.

At scale, pharma companies typically use a combination of specialised software platforms, hub services vendors, and internal coordination teams. The most effective approach consolidates these into a single platform that covers enrolment, therapy support, call centre operations, adherence tracking, and compliance reporting — reducing vendor fragmentation and enabling real-time visibility across programs and geographies.

Patient support programs are run on dedicated PSP platforms, CRM-based solutions adapted for life sciences, or custom-built tools. Purpose-built platforms like Zelthy offer pre-configured templates for specific therapy areas — oncology, immunology, rare disease — with built-in compliance workflows, AI agents for automation, and integrations with pharmacy, claims, and EHR systems.

AI improves PSPs by automating repetitive tasks such as enrolment validation, call scheduling, and document verification. It also enables predictive capabilities — identifying patients at risk of treatment drop-off based on refill patterns, engagement signals, and clinical data. AI-powered adverse event detection during call centre interactions adds a layer of pharmacovigilance that manual processes often miss.

PSPs must comply with a range of regulations depending on the market, including data privacy laws (GDPR, HIPAA), pharmacovigilance reporting obligations (ICH E2B), anti-kickback statutes, and GxP requirements where applicable. A compliant PSP platform enforces role-based access, maintains audit trails, automates adverse event capture, and ensures consent management workflows meet local regulatory standards.

A patient portal is a front-end interface where patients access information, appointments, or documents. A PSP platform is the full operational backbone — it manages enrolment workflows, coordinator task queues, adherence tracking, benefits verification, call centre operations, and regulatory reporting. The portal may be one component of a broader PSP platform, but it is not a substitute for the end-to-end system.

Deployment timelines vary based on therapy complexity and regulatory requirements. Template-based platforms can go live in 4–8 weeks after an initial 1–2 week operational mapping phase. Custom-built solutions from scratch typically take 6–12 months. The template approach significantly reduces time to value while still allowing therapy-specific and market-specific customisation.

Effective PSPs track both operational and clinical metrics: enrolment conversion rates, time-to-therapy, medication adherence rates, patient-reported outcomes (PROs), adverse event capture rates, call centre resolution times, and programme cost per patient. These metrics demonstrate program value to internal stakeholders and payers, and increasingly feed into real-world evidence submissions.

Further Reading

Resources on patient support programs

Ready to rethink patient services?

Talk to our patient services team. We'll walk you through the templates, show you the AI agents in action, and scope deployment for your therapy and market.

Talk to our PSP team